论文部分内容阅读
目的观察异甘草酸镁在重型肝炎(重肝)患者治疗中的临床疗效。方法随机分组,异甘草酸镁(治疗组)30例,复方甘草酸苷(对照组)30例,分别观察两组患者治疗前后肝功能指标的变化。结果异甘草酸镁较复方甘草酸苷更快地降低ALT、TBil水平,有利于肝功能的恢复,两组有统计学意义(P<0.05)。结论异甘草酸镁在重肝患者的临床治疗中,优于复方甘草酸苷。
Objective To observe the clinical effect of isoglycyrrhizinate in the treatment of severe hepatitis (severe liver) patients. Methods Randomly divided 30 patients with magnesium glycyrrhizinate (treatment group) and 30 patients with compound glycyrrhizin (control group), and observed the changes of liver function indexes before and after treatment in both groups. Results Compared with compound glycyrrhizin glycyrrhizin, magnesium and magnesium glycyrrhizinate could reduce ALT and TBil levels, which was beneficial to the recovery of liver function, with statistical significance (P <0.05). Conclusion Isoglycyrrhizin is superior to compound glycyrrhizin in the clinical treatment of patients with severe hepatitis.